PATENT CLAIM ANALYSIS

Application Number: 15891278
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "093700"]

Abstract:
Provided herein are compositions, methods, and kits for proliferating muscle cells by exposing the muscle cells to a prostaglandin E2 (PGE2) compound or compound that activates PGE2 signaling. Also provided are methods for regenerating muscle in a subject suffering from muscular atrophy, dystrophy, and/or injury by administering a PGE2 compound alone or in combination with isolated muscle cells. The PGE2 compound in combination with the isolated muscle cells can be administered prophylactically to prevent a muscle disease or condition.

Claim (Index 37):
The method of  claim 36 , wherein administering comprises an acute, intermittent, or continuous exposure.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 88.0
- Lexical Diversity: 1.66038
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13836794', '13838002', '13431563', '13431499', '13431534']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7449023307257945
- 35 USC 102 Novelty (BERT): 0.5318182970444604
- Combined Prediction Score: 0.7235939273576611
- Mean Citation Score: 275.474916
- Max Citation Score: 281.1653
- Similarity Product: 122.66977517425715

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test